Cargando…
Targeting the Fcμ-receptor in chronic lymphocytic leukemia with a novel IgM-derived antibody-drug conjugate
Autores principales: | Skarzynski, Martin, Vire, Bérengère, Thomas, Joshua D, Nelson, Christopher G, David, Alexandre, Aue, Georg, Burke, Terrence R, Rader, Christoph, Wiestner, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991082/ http://dx.doi.org/10.1186/2051-1426-1-S1-P136 |
Ejemplares similares
-
Identity of the elusive IgM Fc receptor (FcμR) in humans
por: Kubagawa, Hiromi, et al.
Publicado: (2009) -
Mapping of the binding site for FcμR in human IgM-Fc
por: Nyamboya, Rosemary A., et al.
Publicado: (2020) -
Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants
por: Skarzynski, Martin, et al.
Publicado: (2015) -
Reply to: Questioning whether the IgM Fc receptor (FcμR) is expressed by innate immune cells
por: Kubli, Shawn P., et al.
Publicado: (2022) -
The FcμR Limits Tonic BCR Signaling by Regulating IgM-BCR Expression
por: Nguyen, Trang T. T., et al.
Publicado: (2017)